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1. Introduction 
Organic solvents are constantly present in the pharmaceutical production processes. They 
are usually used at any step of the synthesis pathway during the drug product formulation 
process. Organic solvents play an important role in the pharmaceutical industry, and 
appropriate selection of the solvents for the synthesis of drug substance may enhance the 
yield, or determine characteristics such as crystal form, purity, and solubility. Because of 
some physical and chemical property, the solvents are not completely removed by practical 
manufacturing techniques. Usually some small amounts of solvents may remain in the final 
drug product. They are called as residual solvents. Thus, residual solvents in 
pharmaceuticals are defined as organic volatile chemicals that are used or produced in the 
manufacture of drug substances or excipients, or in the preparation of drug products 
(International Conference on Harmonisation of Technical Requirement for Registration of 
Pharmaceuticals for Human Use [ICH], 2009). Since there is no therapeutic benefit from 
residual solvents, all residual solvents should be removed to the extent possible to meet 
product specifications, good manufacturing practices, or other quality-based requirements. 
If the presence of residual solvents in pharmaceuticals exceeds tolerance limits as suggested 
by safety data, they may be harmful to the human health and to the environment. That’s the 
reason that residual solvents testing become one of the important parts of quality control in 
pharmaceuticals. This chapter will review the regulation of residual solvents and methods 
for residual solvents testing and analysis. Special emphasis will be given to the recent 
progress of residual solvents analysis and systematic study on residual solvents analysis in 
pharmaceuticals. 
2. Regulation of residual solvents testing 
The toxicity of residual solvents was recognized by the regulatory agency in the world in 
90’s. The United States Pharmacopeia was the first one that adopted residual solvent testing 
in 22 th edition 3 rd supplement in 1990 (The United States Pharmacopoeia [USP], 1990) 
British Pharmacopeia (1993 edition supplement) (British Pharmacopoeia [BP], 1996), European 
Pharmacopeia (3 rd edition) (European Pharmacopoeia [EP], 1997) and Chinese Pharmacopeia 
(1995 edition) (Pharmacopoeia of the People’s Republic of China [ChP], 1995) subsequently 
adopted residual solvent testing, but only 6-8 residual solvents were controlled at that time. 
(Table 1)  
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Limit (ppm) 
Organic volatile 
impurities 
USP 22 edition 
3rd 
supplement 
BP(1993) 
supplement 
EP 3rd 
ChP 
1995 edition 
Benzene 100 100 100 100 
Chloroform 50 50 50 50 
1,4-Dioxane 100 100 100 100 
Ethylene oxide 10 - - 10 
Dichloromethane 100 100 100 100 
Trichloroethene 100 100 100 100 
Acetonitrile - 50 50 - 
Pyridine - 100 100 100 
Toluene - - - 100 
Table 1. Categories and limits of residual solvents initially controlled in each pharmacopoeia 
At that time, each pharmacopeia used various guidelines for residual solvents control in 
pharmaceutical products with different categories and acceptance limits. Moreover, only 6-8 
residual solvents were controlled, which was far behind from the categories that were really 
used in pharmaceutical industry. Internationally, a standard guideline for control of 
residual solvents is needed to be established. Efforts were made to harmonize the guideline 
for residual solvents by ICH. On 17 July 1997, the Q3C parent guideline on residual solvent 
guidelines and limits was approved by the Steering Committee under Step 4 and 
recommended for adoption the three ICH regulatory bodies. 69 organic solvents that are 
commonly used in pharmaceutical industry were classified in 4 categories by ICH guideline 
(Table 2). Solvents in Class 1 are known carcinogens and should not be employed in the 
manufacture of drug substances, excipients, and drug products because of their 
unacceptable toxicity or their deleterious environmental effect. However, if their use is 
unavoidable in order to produce a drug product with a significant therapeutic advance, then 
their levels should be restricted as shown in Table 2, unless otherwise justified. The limits of 
Class l solvents are usually between 2-8 ppm except 1,1,1-trichloroethane is 1500 ppm, 
which is an environmental hazard. Class 2 solvents are nongenotoxic animal carcinogens. 
Solvents of this class should be limited in pharmaceutical products because of their inherent 
toxicity. The concentration limits of these solvents are in the range of 50 ~ 3880 ppm. Class 3 
solvents have less toxic and lower risk to human health. Class 3 includes no solvent known 
as a human health hazard at levels normally accepted in pharmaceuticals. However, there 
are no long-term toxicity or carcinogenicity studies for many of the solvents in Class 3. They 
are less toxic in acute or short-term studies and negative in genotoxicity studies. The 
concentration limits of these solvents are 5000 ppm. Class 4 solvents are the solvents that 
may also be of interest to manufacturers of excipients, drug substances, or drug products. 
However, no adequate toxicological data was found. Manufacturers should supply 
justification for residual levels of these solvents in pharmaceutical products. 
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Solvent Concentration limit (ppm) 
Class 1 solvents (solvents to be avoided)  
Benzene 2 
Carbon tetrachloride 4 
1,2-Dicloroethane 5 
1,1-Dichloroethene 8 
1,1,1-Trichloroethane 1500 
Class 2 solvents (solvents to be limited)  
Acetonitrile 410 
Chlorobenzene 360 
Chloroform 60 
Cyclohexane 3880 
1,2-Dichloroethene 1870 
Dichloromethane 600 
1,2-Dimethoxyethane 100 
N,N-Dimethylacetamide 1090 
N,N-Dimethylformamide 880 
1,4-Dioxane 380 
2-Ethoxyethanol 160 
Ethyleneglycol 62 
Formamide 220 
Hexane 290 
Methanol 3000 
2-Methoxyethanol 50 
Methylbutyl ketone 50 
Methylcyclohexane 1180 
N-Methylpyrrolidone 4840 
Nitromethane 50 
Pyridine 200 
Sulfolane 160 
Tetralin 100 
Toluene 890 
1,1,2-Trichloroethene 80 
Xylene 2170 
Class 3 solvents (solvents which should be limited by GMP or other qualitybased 
requirements) 
Acetic acid 5000 
Acetone 5000 
Anisole 5000 
1-Butanol 5000 
2-Butanol 5000 
Butyl acetate 5000 
tert-Butylmethyl ether 5000 
Cumene 5000 
Dimethyl sulfoxide 5000 
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Solvent Concentration limit (ppm) 
Ethanol 5000 
Ethyl acetate 5000 
Ethyl ether 5000 
Ethyl formate 5000 
Formic acid 5000 
Heptane 5000 
Isobutyl acetate 5000 
Isopropyl acetate 5000 
Methyl acetate 5000 
3-Methyl-1-butanol 5000 
Methylethyl ketone 5000 
Methylisobutyl ketone 5000 
2-Methyl-1-propanol 5000 
Pentane 5000 
1-Pentanol 5000 
1-Propanol 5000 
2-Propanol 5000 
Propyl acetate 5000 
Tetrahydrofuran 5000 
Class 4 solvents (solvents for which no adequate toxicological data was found) 
1,1-Diethoxypropane Methylisopropyl ketone 
1,1-Dimethoxymethane Methyltetrahydrofuran 
2,2-Dimethoxypropane Petroleum ether 
Isooctane Trichloroacetic acid 
Isopropyl ether Trifluoroacetic acid 
Table 2. List of solvents included in the guideline of ICH  
After the ICH guideline regarding residual solvents in pharmaceuticals became official in 
1997, consequently, pharmacopeias of different countries have adopted it and have 
revised their general methods to reflect it. EP (3rd edition) was the first one that accepted 
ICH guideline with the same categories and limits of residual solvents. In general chapter: 
Identification and control of residual solvents, general methods for residual solvent 
determination were described. Gas chromatography (GC) with headspace injection is 
proposed in both systems. Two procedures (systems), A and B, are presented, and System 
A is preferred whilst System B is employed normally for confirmation of identity (EP, 
1999). Japanese Pharmacopoeia accepted ICH guideline in 14th edition (Japanese 
Pharmacopoeia [JP], 2001). ICH guideline was accepted by Chp in 2005 edition (Chp, 
2005). Three methods were used to screening and analysis residual solvents in 
pharmaceuticals: Isothermal temperature HS-GC method, Programmed temperature HS-
GC method, and direct injection method. Until USP 28, residual solvents testing was 
finally updated to comply with ICH guideline. Current official methods for residual 
solvent determination are described in <467> chapter Organic Volatile Impurities. Three 
procedures (A, B, C) for water-soluble and water-insoluble articles, are available. 
Procedures A and B are useful to identify and quantify residual solvents, when the 
information regarding which solvents are likely to be present in the material is not 
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available. In cases when we have information about residues of solvents that may be 
expected in the tested material, only procedure C is needed for quantification of the 
amount of residual solvents (USP, 2005).  
3. Methods for residual solvents analysis 
In the early stage, one of the simplest methods for determining the content of volatile 
residues consists in measuring the weight loss of a sample during heating. However, this 
method suffers the great disadvantages of being totally non-specific (multicomponent 
solvent blends cannot be analysed and there will always be a doubt on humidity 
contamination) and of needing several grams of product to achieve a detection limit of 
about 0.1% (Benoit, 1986; Dubernet, 1990; Guimbard, 1991). Nevertheless, when carried out 
by thermogravimetry, the limit can be lowered to 100 ppm using only a few milligrams of 
substance (Guimbard, 1991). Infrared spectroscopy (IR) (Osawa & Aiba, 1982) and Fourier 
Transform Infrared Spectrometry (FTIR) (Vachon & Nairn, 1995) were used to determine 
residual Tetrahydrofuran (THF), dichloroethane and methylene chloride in polymer 
samples by measuring the characteristic solvent bands in the spectra. The most common 
limiting factors in these methods are possible interferences of solvent and matrix peaks and, 
in the case of IR, the high detection limit (above 100 ppm) and a lack of accuracy at low 
concentrations (Weitkamp & Barth, 1976). Avdovich et al. determined benzene, toluene, 
acetone, methyl ethyl ketone and ethyl ether (in a few samples also methylene chloride and 
ethyl acetate) in cocaine samples by NMR, which allowed a quantification down to 100 ppm, 
with possibly detection or identification problems in the case of ethyl ether and methyl ethyl 
ketone at these low levels (Avdovich, 1991). However, these detection limits are too high to 
satisfy the requirements relating to residual solvents determination, especially for the most 
toxic solvents. 
The methods mentioned above were replaced by GC. GC is the natural choice for residual 
solvent analysis. Firstly, because of its excellent separation ability, according to the 
chromatographic conditions and the column and, secondly, because of its low detection 
limits and the possibility of analysing liquid or solid samples of a complex nature. Modern 
capillary-column GC can separate a large number of volatile components, permitting 
identification through retention characteristics and detection at ppm levels using a broad 
range of detectors. The most popular detectors are: the flame ionization detector (FID), 
which is a rather universal detector for organic volatile compounds; and, the electron 
capture detector (ECD), which is especially suited to detection of halogenated compounds. 
However, FID is by far the most preferred for release-related tasks because of its low 
detection limits, wide linear dynamic range, robustness, ease of operation, and general 
reliability and utility, especially for trace organic compounds. There are three type of GC 
classed by different sample preparation procedures: direct-injection GC, headspace (HS) GC 
and solid-phase microextraction (SPME) GC. Application of these three GCs in residual 
solvent analysis will be reviewed below. 
3.1 Direct-injection GC 
Residual solvent determination using direct-injection sample preparation is the oldest 
technique, and, historically, it was preferred because of its simplicity, reliability, ease of 
operation and throughput (Witschi & Doelker, 1997). The drug substance or the formulation 
is dissolved in or extracted with a high-boiling-point solvent, such as water, 
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dimethylsulfoxide (DMSO), dimethylformamide (DMF), dimethylacetamide (DMA), benzyl 
alcohol (BA) or ethylene glycol. Using high-boiling-point solvents has the advantage that the 
diluent solvent peak will elute later, thus not interfering with the earlier eluting analyte 
peaks. However, it has the big disadvantage that non-volatile components, such as the drug 
substance or the formulation components, are also injected, and that leads to injector 
contamination, column contamination and deterioration, together with unavoidable matrix 
effects. Furthermore, as the matrix is also injected onto the column, this must be eluted prior 
to beginning the next injection, and that has the effect of prolonging the analytical run. From 
Witschi and Doelker (Witschi & Doelker, 1997) and Hymer’s (Hymer, 2003) reviews, the 
data in the literature on direct injection applications was summarized up to 2003. It was 
evident from the trend that, in more recent times, based on the number of publications, the 
interest of industry-research groups has shifted to other sample-preparation techniques, 
such as static headspace and sorbent-based approaches. 
3.2 Headspace GC 
Two types of HS sampling are available: dynamic HS analysis (also called purge-and-trap); 
and static HS analysis. The theory of static headspace is thoroughly described in three books, 
by Hachenberg and Schmidt (Hachenberg & Schmidt, 1977), Loffe and Vitenberg (Loffe & 
Vitenberg, 1984), and Kolb and Ettre (Kolb & Ettre, 2006). It was summarized by Snow and 
Bullock as below (Snow & Bullock, 2010). In HS extraction, the vapor phase directly above 
and in contact with a liquid or solid sample in a sealed container is sampled and an aliquot is 
transferred to a GC for separation on a column, detection and quantitation. The ability to 
determine the amount of a substance within a liquid or solid sample by analyzing the 
headspace vapor above it in a closed vessel derives from three critical fundamental 
principles: Dalton’s Law, Raoult’s Law and Henry’s Law. Generally, static HS sampling is the 
most widely used technique for residual solvent determination in pharmaceuticals. This fact 
comes from some of the advantages of this technique, mainly that only volatile substances 
and dissolution medium can be injected onto the column. Also HS systems are fully 
automated, in addition, a sample preparation is easy, and the sensitivity of analysis is 
sufficient for the majority of solvents mentioned in ICH guidelines. Static HS sampling is 
based on thermostatic partitioning of volatile compounds in a sealed vial between the sample 
diluent and the gas phase. Sample diluent is a critical factor affecting HS-GC method sample 
load, sensitivity, equilibration temperature and time. A good sample diluent for analyzing 
residual solvents in pharmaceutical products should have a high capability for dissolving a 
large amount of samples, a high boiling point and a good stability. There are a number of 
commonly used sample diluents for HS analysis, such as water, DMSO, DMF, DMA, BA, 1,3-
dimethyl-2-imidazolidinone (DMI), and mixtures of water-DMF or water-DMSO. For water-
soluble samples, water is the choice of diluent. The influence of the matrix medium used for 
the determination of residual solvents in pharmaceuticals was investigated by Urakami et al 
(Urakami et al, 2004). A guide for the choice of a matrix medium suitable for the 
determination of residual solvents was proposed. Water, DMSO, DMF, DMA, BA, DMI were 
studied as matrix media, and seventeen solvents were used as target analytes. The peak 
shapes of each analytes were not affected by the matrix medium, whereas the peak intensities 
for all solvents were strongly affected by the matrix medium. Otero et al established a static 
HS GC method for quantitative determination of residual solvents in a drug substance 
according to European Pharmacopoeia general procedure. A water-dimethylformamide 
mixture is proposed as sample solvent to obtain good sensitivity and recovery (Otero et al, 
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2004). Recently, ion liquid was used as matrix medium in HS analysis in residual solvent 
analysis. Liu et al used a new solvent room temperature ionic liquid (1-butyl-3-
methylimidazolium teterafluoroborate) as matrix medium in static HS to determine residual 
solvents in pharmaceutical. Six residual solvents were analyzed and better sensitivities were 
gained with it as diluent comparing with DMSO (Liu & Jiang, 2007). Laus et al reported that 
1-n-Butyl-3-methylimidazolium dimethyl phosphate (BMIM DMP) was identified as the most 
suitable ionic liquid as solvent for the HS-GC analysis of solvents with very low vapor 
pressure such as dimethylsulfoxide, N-methylpyrrolidone, sulfolane, tetralin, and ethylene 
glycol (Laus et al, 2009). The main drawback of static HS is the lower detection limit 
compared to dynamic HS. Partition Coefficient (K) is the key factor that affects the sensitivity 
of HS analysis, which represented the concentration ratio of a volatile in the liquid and gas 
phase at a defined temperature and pressure at equilibrium stage. Substance with low 
partition coefficient (K < 10-100) is easier to go to the gas phase, and is considered to suitable 
for HS analysis. Several methods are available for reducing the partition coefficient of 
volatiles, in particular in aqueous systems, and thus to improve the HS sensitivity, such as 
salting-out, pH adjustment or increasing the equilibration temperature of the sample. 
Dynamic headspace sampling technique involves the passing of carrier gas through a liquid 
sample, followed by trapping of the volatile analytes on a sorbent and desorption onto a GC. 
A major advantage of this technique is that a thermodynamic equilibrium is not necessarily 
needed, and the sensitivity of the method is increased by enrichment of the anlaytes on the 
trap. Consequently, limit of detection reported for dynamic headspace are lower (pg/ml) 
than those obtained with static headspace (ng/ml) (Arthur & Pawliszyn, 1990). Therefore, the 
automation of the instrument and reproducibility of the results are not as good as static 
headspace, so the application of purge and trap in residual solvent analysis was not popular.  
Dynamic headspace analysis is particular suited for the determination of volatile residual 
solvents at very low concentrations. Recently, Lakatos reported that four Class 1 solvents 
were analyzed in a water-soluble drug using dynamic headspace technique. The results 
show that the Purge and trap technique is more sensitive than the static headspace. 
Repeatability, accuracy and the linearity were examined, and these characteristics of the 
method were proved to be suitable for residual solvent analysis. It was found that the Purge 
and trap could be an alternative sample preparation method besides the static headspace 
method (Lakatos, 2008).  
3.3 Solid-phase microextraction GC 
SPME, in which a small amount of extracting phase, a stationary phase is coated on a 
support. Commonly, a fused silica fiber is used. The extracting phase is placed in contact 
with the sample matrix for a predetermined amount of time. If the time is long enough, a 
concentration equilibrium of the volatile analyte is established between the sample matrix 
and the extraction phase, then the analytes adsorbed on the fiber are thermally desorbed in 
the injector of the GC. In general, two types of SPME extractions can be performed. The first 
type, “Direct extraction” or “immersion” involves bringing the SPME fiber in contact with 
the sample matrix. The second type of SPME is headspace SPME, in which, the volatile 
analytes need to be transported through the barrier of air above the sample before they can 
reach the SPME extracting phase. It helps to protect the fiber coating from damage by high 
molecular-mass and other non-volatile interferers present in the sample matrix. Since the 
headspace SPME was developed in 1993 and has experienced the strongest growth in 
research interest over the past decade. Advantages of SPME include simplicity of execution, 
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low cost of the instrument and less solvent consume. Headspace SPME attracted more 
attention in residual solvent testing area due to it can avoid the interference from the non-
volatile pharmaceuticals. Camarasu et al used two types of SPME methods to determine 
residual solvents in pharmaceuticals. Three fibers with different polymer films were 
compared and the polydimethylsiloxane/divinylbenzene coated fiber was found to be the 
most sensitive one for the analyzed analytes. Bewteen the investigated sample preparation 
techniques, gastight-SPME proved to be the most sensitive one. Headspace SPME is more 
precise. Compared with the static headspace technique, SPME method showed superior 
results (Camarasu et al, 1998). Another paper from Camarasu reported that an SPME 
method has been developed and optimized for the polar residual solvents determination in 
pharmaceutical products. The headspace SPME from aqueous solutions was found to be ten 
times more sensitive than Immersion SPME and Headspace SPME from organic solutions 
(Camarasu, 2000) 
3.4 Recent progress  
A new method for direct determination of residual solvents in solid drug product using 
multiple headspace sing-drop microextraction (MHS-SDME) was reported by Yu et al. The 
MHS-SDME technique is based on extrapolation to an exhaustive extraction of consecutive 
extractions from the same sample which eliminates the matrix effect on the quantitative 
analysis of solid samples. Factors affecting the performance of MHS-SDME including 
extraction solvent, microdrop volume, extraction time, sample amount, thermostatting 
temperature and incubation time were studied. Experimentally, a model drug powder was 
chosen and the amounts of residues of two solvents, methanol and ethanol were investigated. 
Quantitative results of the proposed method showed good agreement with the traditional 
dissolution method. Compared with the conventional method for determination of residual 
solvents, the MHS-SDME technique can eliminate possible memory effects with less organic 
solvents. The results also indicated that MHS-SDME had a great potential for the quantitative 
determination of residual solvents directly from the solid drug products due to its low cost, 
ease of operation, sensitivity, reliability and environmental protection (Yu et al, 2010).  
A novel on-line solvent drying technique has been described that is capable of simultaneously 
measuring the solvent end point in vapor phase and maintaining high accuracy with 
precision. The technique used non-contact infrared sensor for monitoring the solvent vapors 
during the pharmaceutical solvent drying process. The data presented demonstrated that 
on-line combined with non-contact sensor method had high degree of precision and 
accuracy for monitoring the end point of the solvent drying (Tewari et al, 2010).  
4. Systematic study of analysis residual solvents in pharmaceuticals-
database 
Analysis of residual solvent is known to be one of the most challenging analytical tasks in 
pharmaceutical analysis and control. The challenge is due to the different manufacturer 
produce the same pharmaceutical products using different manufacturing processes. 
Unknown peaks are often detected during routine quality control testing using GC. When 
this happened, the only thing we can do is to try different solvent standards to find out 
which has the same retention time with the unknown peak. It is a time consuming work, 
sometimes the unknown peak is not a residual solvent, but an interference peak. To address 
this problem, a systematic study was conducted by our laboratory; three databases were 
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established for fast screening, confirmation and method optimization in the analysis of 
residual solvents in pharmaceuticals. These three databases were published separately (Liu 
& Hu, 2006, 2007, 2009) and were combined here for a better understanding purpose since 
they are three parts of the intact database for residual solvent analysis. 
4.1 Screening database 
4.1.1 Establishment of screening database 
When analysis residual solvent using GC, unknown peaks often show up. It is hard to tell 
the unknown peak is another residual solvent or interference peak. Moreover, some organic 
solvents controlled by ICH have the same retention time on a GC column. To solve these 
problems, a database for preliminary screening of residual solvents in pharmaceuticals has 
been established using the parallel dual-column system. The basic principle is that different 
compounds may have the same retention times on one column, but it is highly unlikely that 
different compounds will have the same retention times on another column with opposite 
polarities. So if an organic solvent is present in both columns in the screening procedure, 
then it is a suspect residual solvent in pharmaceutical. The establishment and application of 
the screening database were described in one of article published by our lab (Liu & Hu, 
2007). Two columns with different polarities, SPB-1 and HP-INNOWAX, connected with a 
‘Y’ splitter, constituted the dual pathways system. Fifty-two solvents that suitable for static 
headspace analysis were studied according to the guidelines for residual solvents regulated 
by ICH on this system. The retention times of 52 organic solvents in both systems were 
recorded under the above conditions. The dead time was determined using methane, and 
the adjusted retention times of each solvent were calculated. The relative retention times 
(RRTs) of each solvent in both systems were then calculated as follows, using methyl ethyl 
ketone (MEK) as the reference standard. 
 RRT= [tR(compound)-t0]/[tR(MEK)-t0] (1) 
Where tR is the retention time of the compound, and t0 is the retention time of methane. The 
RRT was selected as the basis of identification. The RRTs of the 52 organic solvents in both 
systems constituted the database (Table 3).  
 
 
Fig. 1. Schematic diagram of parallel-column system and two chromatograms of all of 52 
organic solvents obtained from the system in a single run 
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Non-polar system SPB－1 Polar system HP－INNOWAX 
Order Organic solvent tR(min) RRT Order Organic solvent tR(min) RRT 
1 methanol 1.872 0.135 1 pentane 2.432 0.038 
2 ethanol 2.155 0.274 2 hexane 2.607 0.081 
3 acetonitrile 2.237 0.315 3 ethyl ether 2.675 0.098 
4 acetone 2.345 0.368 4 isooctane 2.848 0.141 
5 2-propanol 2.447 0.419 5 isopropyl ether 2.850 0.141 
6 pentane 2.557 0.473 6 tert-butyl methyl ether 2.928 0.161 
7 ethyl ether 2.568 0.479 7 heptane 2.987 0.175 
8 ethyl formate 2.600 0.495 8 cyclohexane 3.232 0.236 
9 1,1-dimethoxymethane 2.672 0.530 9 1,1-dichloroethene 3.277 0.247 
10 1,1-dichloroethene 2.687 0.538 10 1, 1,1-dimethoxymethane 3.348 0.264 
11 methyl acetate 2.730 0.559 11 methylcyclohexane 3.652 0.339 
12 dichloromethane 2.733 0.560 12 acetone 4.378 0.518 
13 nitromethane 2.903 0.644 13 ethyl formate 4.492 0.547 
14 1-propanol 3.135 0.759 14 methyl acetate 4.562 0.564 
15 1,2-dichloroethene 3.222 0.802 15 1,2-dichloroethene 5.190 0.719 
16 tert-butyl methyl ether 3.407 0.894 16 tetrahydrofuran 5.217 0.725 
17 methyl ethyl ketone 3.622 1.000 17 methyl tetrahydrofuran 5.378 0.765 
18 2-butanol 3.892 1.134 18 1,1,1-trichloroethane 5.692 0.843 
19 hexane 4.072 1.223 19 carbon tetrachloride 5.693 0.843 
20 isopropyl ether 4.103 1.238 20 ethyl acetate 5.893 0.892 
21 ethyl acetate 4.122 1.247 21 isopropyl acetate 6.250 0.980 
22 chloroform 4.127 1.250 22 methyl ethyl ketone 6.330 1.000 
23 tetrahydrofuran 4.537 1.453 23 methanol 6.358 1.007 
24 2-methyl-1-propanol 4.560 1.464 24 1,2-dimethoxyethane 7.270 1.232 
25 1,2-dichloroethane 4.788 1.577 25 2-propanol 7.390 1.262 
26 1,1,1-trichloroethane 5.047 1.705 26 methyl isopropyl ketone 7.400 1.264 
27 methyl isopropyl ketone 5.310 1.835 27 dichloromethane 7.470 1.281 
28 1,2-dimethoxyethane 5.348 1.854 28 ethanol 7.802 1.363 
29 benzene 5.563 1.960 29 benzene 7.827 1.369 
30 isopropyl acetate 5.652 2.004 30 propyl acetate 9.355 1.746 
31 1-butanol 5.718 2.037 31 1,1,2-trichloroethene 9.937 1.890 
32 carbon tetrachloride 5.743 2.049 32 methyl isobutyl ketone 10.495 2.028 
33 cyclohexane 5.903 2.128 33 acetonitrile 10.503 2.030 
34 methyl tetrahydrofuran 5.997 2.175 34 isobutyl acetate 10.655 2.067 
35 1,1,2-trichloroethene 7.143 2.741 35 chloroform 10.980 2.147 
36 isooctane 7.278 2.808 36 2-butanol 11.182 2.197 
37 1,4-dioxane 7.337 2.837 37 toluene 11.568 2.292 
38 heptane 7.883 3.107 38 1-propanol 11.610 2.303 
39 propyl acetate 7.997 3.164 39 1,4-dioxane 12.258 2.463 
40 methylcyclohexane 8.933 3.627 40 1,2-dichloroethane 12.463 2.513 
41 methyl isobutyl ketone 9.177 3.747 41 butyl acetate 12.540 2.532 
42 3-methyl-1-butanol 9.270 3.793 42 methyl butyl ketone 12.800 2.596 
43 pyridine 9.652 3.982 43 2-methyl-1-propanol 13.170 2.688 
44 toluene 10.548 4.425 44 1-butanol 14.355 2.980 
45 1-pentanol 10.737 4.519 45 cumene 15.030 3.147 
46 isobutyl acetate 10.932 4.615 46 nitromethane 15.065 3.155 
47 methyl butyl ketone 11.278 4.786 47 pyridine 15.357 3.227 
48 butyl acetate 12.428 5.355 48 3-methyl-1-butanol 15.747 3.323 
49 chlorobenzene 13.375 5.823 49 chlorobenzene 16.015 3.390 
50 anisole 15.443 6.846 50 1-pentanol 16.618 3.538 
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Non-polar system SPB－1 Polar system HP－INNOWAX 
Order Organic solvent tR(min) RRT Order Organic solvent tR(min) RRT 
51 cumene 15.887 7.066 51 anisole 18.523 4.008 
52 tetralin 22.778 10.474 52 tetralin 23.303 5.188 
 methane 1.600   methane 2.277  
Table 3. The relative retention times of 52 organic solvents on non-polar system and polar 
system 
4.1.2 Applications of the database 
4.1.2.1 Screening the residual solvents in parmacuticals in a single run 
Amoxicillin sodium and clavulanate potassium (5:1), an antibacterial drug registered by a 
foreign company in China, was analyzed. The preliminary screening results (Table 4) were 
obtained simultaneously in a single run. According to Table 4, the solvents that appeared on 
both column systems simultaneously may be the residual solvents in the pharmaceuticals. 
The possible residual solvents were acetone, methyl acetate, ethyl acetate and 2-propanol in 
this case. All of these solvents were mentioned by the manufacturer, except for methyl 
acetate. It was confirmed by the reference standard. The confirmation database was used to 
give further identification of this peak, and the results indicated that the peak was indeed 
methyl acetate (4.2.3.1). Finally, the manufacturer admitted that methyl acetate was actually 
used in the manufacturing process, but for some reason it was not disclosed in the 
manufacturer’s product information sheet. In addition, although only 4 out of the 8 
impurities detected in Table 4 could be identified as residual solvents, it showed that the 
database could eliminate the interference of thermal degradation products or other volatile 
impurities (which were not the 52 residual solvents we concerned), which was one of the 
advantages of the database. 
4.1.2.2 Eliminating the interference of co-elution  
Potassium clavulanate and cellulose microcrystallistate (1:1), an enzyme inhibitor of β-
lactamase, was registered by a foreign company in China. The content of methanol was 
reported much higher than the limit specified by the ICH in the routine residual solvent test. 
The database was used to check this result. The preliminary screening results are given in 
Table 5. 
According to Table 5, the solvents that appeared on both column systems simultaneously 
may be the residual solvents in the pharmaceutical product. The possible residual solvents 
in the drugs were acetone and 2-propanol without methanol. If the peak whose RRT was 
0.129 was judged only according to the results of SPB-1, it would definitely be identified as 
methanol, but on the HP-INNOWAX there was no peak with the RRT of methanol. 
Therefore, this peak was not methanol and was not included in the 52 residual solvents; it 
might be a degradation product from the headspace process. The database can eliminate the 
interference of co-elution and avoid false positive result. 
4.2 Confirmation database 
Mass spectrometry (MS) and FTIR are powerful tools for identification of organic 
compounds. GC is the most common technique for separation of volatile and semi-volatile 
mixtures. It is well accepted that when GC is coupled with spectral detection methods, such 
as FTIR or MS that the resulting combination is a powerful tool for the separation and   
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Column Number tR(min) RRT Data in database Possible residual 
solvents 
1 2.352 0.369  0.368 acetone* 
2 2.445 0.416  0.419 2-propanol* 
0.556  3 2.727 
 
0.538 
0.559 
0.560 
1,1-dichloroethene 
methyl acetate* 
dichloromethane 
4 3.807 1.092  1.134 2-butanol 
1.255 
 
 
5 4.135 
 
1.223 
1.238 
1.247 
1.250 
hexane 
isopropyl ether 
ethyl acetate* 
chloroform 
2.113  6 5.863 
 
2.037 
2.049 
2.128 
2.175 
1-butanol 
carbon tetrachloride 
cyclohexane 
methyl 
tetrahydrofuran 
7 8.697 3.520  3.627 methylcyclohexane 
 
 
 
 
 
 
 
SPB-1 
8 17.988 8.133  no corresponding data  
1 3.080 0.197 no corresponding data  
2 4.347 0.510 0.518 acetone* 
3 4.563 0.563 0.547 
0.564 
ethyl formate 
methyl acetate* 
4 5.913 0.897 0.892 ethyl acetate* 
5 6.308 0.995 0.980 
1.000 
1.007 
isopropyl acetate 
methyl ethyl ketone 
methanol 
6 7.425 1.271 1.232 
1.262 
1.264 
1,2-dimethoxyethane 
2-propanol* 
methyl isopropyl 
ketone 
7 7.702 1.339 1.363 
1.369 
ethanol 
benzene 
 
 
 
 
 
HP-INN 
OWAX 
8 16.808 5.590 no corresponding data  
Note: The organic solvents appeared in both columns were marked with *.  
Table 4. The preliminary screening results of the SPB-1 column and the HP-INNOWAX 
column 
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Column Number tR 
(min) 
RRT Data in database Possible residual solvents 
1 1.878 0.129 0.135 methanol 
2 2.363 0.368  0.368 acetone* 
3 2.458 0.415 0.419 2-propanol* 
 
SPB-1 
4 4.832 1.588 1.577 1,2-dichloroethane 
1 3.037 0.194 no corresponding data  
2 4.287 0.505 0.518 acetone* 
3 7.310 1.258 1.232 
1.262 
1.264 
1,2-dimethoxyethane 
2-propanol* 
methyl isopropyl ketone 
 
 
HP-IN 
NOWAX 
4 11.543 2.311 2.292 
2.303 
toluene 
1-propanol 
Note: The organic solvents appeared in both columns were marked with *.  
Table 5. The preliminary screening results of the SPB-1 column and the HP-INNOWAX 
column 
identification of components in complex mixtures. Gas chromatography-mass spectrometry 
(GC-MS) has superior detection limits and is widely used in qualitation of volatile organic 
compound. Gas chromatography-fourier transform infrared spectrometry (GC-FTIR) also 
has applications in the identification for compound. The combination application of mass 
spectra and FTIR spectra is a very powerful coupling because of the complementary nature 
of the data acquired, which will make the confirmation more confident. Another problem is 
that the residual solvents testing is trace analysis, usually the concentration of residual 
solvent in the drugs is very low. So it was hard to get good results using the commercial MS 
spectra library when the analytes at low concentration. To address this issue, 60 organic 
solvents introduced by ICH were studied using GC-MS and GC-FTIR. The standard mass 
spectra library, limit of detection (LOD) mass spectra library, standard vapor-phase infrared 
spectra library and limit of detection (LOD) vapor-phase infrared spectra library were 
obtained to establish a confirmation database for determining residual solvents in 
pharmaceuticals. The confirmation database can be used to identify the unknown residual 
solvents without using reference organic solvents. 
4.2.1 Establishment of the confirmation database 
One microliter of each stock standard solution was injected into the GC-MS system and the 
mass spectra and the retention time of the organic solvents were recorded. The limit of 
detection was considered as the quantity of analyte that generated a response three times 
greater than the noise level at the retention time by diluting the stock standard solutions as 
required, and the mass spectra of organic solvents were recorded. The mass spectra library 
was established with Xcalibur software by exporting to the Library Brower a spectrum that 
had background subtracted and then attaching the chemical structure, compound name, 
molecular weight and molecular formula among other standard characteristics. 
One microliter of each stock standard solution was injected into the GC-FTIR system and the 
vapor-phase infrared spectra and the retention time of organic solvents were recorded. The 
limit of detection was considered as the quantity of analyte that generated a response ten 
times greater than the noise lever at the retention time in the Gram-Schmidt chromatogram. 
This limit was achieved by diluting the stock standard solutions as required, and the vapor-
phase infrared spectra of organic solvents were recorded. The vapor-phase infrared spectra 
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library was established with OPUS software by exporting to the library a spectrum that had 
background subtracted and attaching an information mask that included compound name, 
molecular weight, molecular formula, melting point, boiling point and other standard 
characteristics. 
4.2.2 Mass spectra library and vapor-phase infrared spectra library can verify and 
complement each other  
The advantages of mass spectra in compound identification include the ability to give the 
molecular weight of compound, the ability to distinguish homologues, and superior 
detection limits. The LODs of organic solvents are usually in the picogram range. The main 
limitations of mass spectra include the inability to give the intact information of compound 
and the inability to distinguish closely related isomers. The advantages of FTIR spectra in 
compound identification are that it can give information about the intact molecule, and 
similar structures such as isomers can be distinguished. The main limitation of infrared is 
lower sensitivity. Obviously, the combination application of mass spectra and FTIR spectra 
is a very powerful coupling because of the complementary nature of the data acquired. If 
mass spectra and infrared spectra give the same result, then the result can be considered 
accurate with greater confidence.  
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Fig. 2. (a) Mass spectra of (1)1,1-Dichloroethene and (2)1,2-Dichloroethene. (b) Vapor-phase 
infrared spectra of (1)1,1-Dichloroethene and (2)1,2-Dichloroethene  
Of the 60 organic solvents were determined, 1,1-Dichloroethene and 1,2-Dichloroethene 
were isomers. They had very similar mass spectra (Fig. 2.a), and they were difficult to 
distinguish in the mass spectra library search. But their vapor-phase infrared spectra 
showed a significant difference (Fig. 2.b). 
Isomers that had very similar mass spectra were suited for determination by a vapor-phase 
infrared spectra library; the normal alkanes(homologs) which had simple vapor-phase 
infrared spectra (Fig. 3.a) were suited for determination by mass spectra library (Fig. 3.b). 
4.2.3 Applications of the confirmation database 
4.2.3.1 Confirmation for the residual solvents that were preliminarily identified in 
pharmaceuticals  
Amoxicillin sodium and clavulanate potassium (5:1), an antibacterial medicine registered by 
a foreign company, was analyzed by the screening database. According to the screening  
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Fig. 3. (a) Vapor-phase infrared spectra of (1) hexane and (2) heptane. (b) Mass spectra of (1) 
hexane and (2) heptane 
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results, acetone, isopropanol and methyl acetate were found in the product. Besides acetone 
and isopropanol were used in the synthesis, methyl acetate was not included. The 
confirmation database was used to confirm the screening results. According to the result 
from GC-MS, Ethyl acetate was the rank 1 compound according to the standard mass 
spectra library, and the similarity value was 913 (Fig. 4.a). The sample was analyzed by GC-
FTIR using the standard vapor-phase infrared spectra library. Methyl acetate was also the 
rank 1 compound, and the similarity value was 983 (Fig. 4.b). The screening result was 
confirmed by the confirmation database, and methyl acetate was confirmed in the product. 
4.3 Method optimization database 
After the databases for screening and confirmation of residual solvents in pharmaceuticals 
were established, our next challenge is to focus on systematic method development and 
optimization, such as the fast selection of appropriate columns and optimization of 
chromatographic conditions. The solvation parameter model was applied in the 
development of a method for the analysis of residual solvents in pharmaceuticals. The 
interactions between organic solvents and six different stationary phases were studied using 
gas chromatography. The retention times of the organic solvents on these columns could be 
predicted under isothermal or temperature-programmed conditions using the established 
solvation parameter models. The predicted retention times helped in column selection and 
in optimizing chromatographic conditions during method development, and will form the 
basis for the development of a computer-aided method.  
The solvation parameter model, first introduced by Abraham (Abraham, 1994a, 1994b, 
1997), is a useful tool for delineating the contribution of defined intermolecular interactions 
to the retention of neutral molecules in separation systems based on a solute equilibrium 
between a gas mobile phase and a liquid stationary phase. The solvation parameter model in 
a form suitable for characterizing the retention properties of stationary phases in gas-liquid 
chromatography is shown below (Abraham, 2004): 
 SP = c + eE + sS +aA +bB +lL (2) 
Where SP, is the gas chromatography retention data for a series of solutes. c is the model 
intercept, the lower case letters (e, s, a, b, l) are the system constants representing the 
stationary phase contribution to intermolecular interactions. l, for the contribution from 
cavity formation and solute-stationary phase dispersion interactions; e, for the capacity of the 
phase to interact with n- and ┨-electrons present in the solute; s, for the ability to interact with 
dipoles of the solute; a and b for the facility to interact with basic or acid solutes through 
hydrogen-bond forces, respectively. 
The capital letters (E, S, A, B, L) are the solute descriptors for the complementary 
interactions with the system constants of the stationary phase. L being the gas-hexadecane 
partition coefficient; E, the molar refraction excess; S, the effective dipolarity/polarizability 
of the solute; A, the hydrogen-bond effective acidity of the solute; B, the hydrogen-bond 
effective basicity of the solute. 
4.3.1 Prediction of retention time under isothermal conditions 
The chromatographic columns used in this work were: SPB-1 (100% dimethyl siloxane,  
30.0 m×0.32 mm×1 μm ); HP-5 (5% diphenyl, 95% dimethyl siloxane, 30.0 m×0.53 mm×1.5 
μm, used in Table 2); HP-5 (5% diphenyl, 95% dimethyl siloxane, 30.0 m×0.32 mm×0.25 μm); 
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HP-35 (35% diphenyl, 65% dimethyl siloxane, 30.0 m×0.53 mm×1 μm); DB-624  
(6% cyanopropylphenyl, 94% dimethyl siloxane, 30.0 m×0.53 mm×3 μm); AT-225  
(50% cyanopropylphenyl, 50% dimethyl siloxane, 30.0 m×0.32 mm×0.25 μm); ZB-WAX 
(100% polyethylene glycol, 30.0 m×0.32 mm×1 μm). The retention times of 39 organic 
solvents were determined on six columns at 40°C, 60°C, 80°C and 100°C. The dead time was 
determined using methane, and the RRTs of each organic solvent on each column were 
calculated using Eq. (1). 
The system constants of these columns were obtained using Eq.(2) by multiple linear 
regression analysis. SP in this case was RART. The solute descriptors were taken from the 
literature (Kiridena, 2001; Abraham, 1993; Poole, 2002)], and are listed in Table 6. Multiple 
linear regression and statistical calculations were performed using SPSS software. 
 
 
(a) 
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(b) 
Fig. 4. Search result from (a) the standard mass spectra library and (b) the standard vapor-
phase infrared spectra library (1) Spectrum of methyl acetate in the standard vapor-phase 
infrared spectra library (2) Spectrum of the residual solvent to be determined 
The procedure for predicting retention time under isothermal conditions included the 
following steps:  
i. The column t0 is determined using methane, and tR is measured for the standard (MEK).  
ii. The value of LogRRT is calculated using the solvation parameter model and the known 
system constants and solute descriptors (Abraham, 1999).  
iii. The retention time of the residual solvent is calculated from Eq. (1). 
4.3.2 Prediction of retention time under temperature-programmed conditions 
According to Cavalli’s theory (Cavalli & Guinchard, 1995, 1996), retention time under 
temperature-programmed conditions can be calculated using only a few sets of isothermal 
experiments. The hypothesis is that, in temperature-programmed gas chromatography, the 
column acts as a series of short elements undergoing a succession of isothermal stages. The 
retention factor of the solute (k) decreases with increased column temperature and the 
logarithm of retention factor (ln k) has a linear correlation with the reciprocal of column 
temperature (T). A and B can easily be determined experimentally from the linear regression 
using the following formula: 
 R
0
ln ln (  -1)
t A
k B
t T
= = +  (3) 
where T is the oven temperature, A and B are fitting coefficients. 
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Solute descriptors   
Organic solvents E S A L B 
1 1,1,1-Trichloroethane 0.369 0.41 0 2.733 0.09 
2 1,1,2-Trichloroethene 0.524 0.4 0.08 2.997 0.03 
3 1,1-Dichloroethene 0.362 0.34 0 2.11 0.05 
4 1,1-Dimethoxymethane 0.099 0.46 0 1.894 0.52 
5 1,2-Dichloroethene 0.425 0.41 0.09 2.278 0.05 
6 1,2-Dimethoxyethane 0.116 0.67 0 2.654 0.68 
7 1-Butanol 0.224 0.42 0.37 2.601 0.48 
8 1-Propanol 0.236 0.42 0.37 2.031 0.48 
9 2-Butanol 0.217 0.36 0.33 2.338 0.56 
10 2-Methyl-1-propanol 0.217 0.39 0.37 2.413 0.48 
11 2-Propanol 0.212 0.36 0.33 1.764 0.56 
12 Acetone 0.179 0.7 0.04 1.696 0.49 
13 Acetonitrile 0.237 0.9 0.07 1.739 0.32 
14 Benzene 0.61 0.52 0 2.786 0.14 
15 Carbon tetrachloride 0.458 0.38 0 2.823 0 
16 Chloroform 0.425 0.49 0.15 2.48 0.02 
17 Cyclohexane 0.305 0.1 0 2.964 0 
18 Dichloromethane 0.387 0.57 0.1 2.019 0.05 
19 Ethanol 0.246 0.42 0.37 1.485 0.48 
20 Ethyl acetate 0.106 0.62 0 2.314 0.45 
21 Ethyl ether 0.041 0.25 0 2.015 0.45 
22 Ethyl formate 0.146 0.66 0 1.845 0.38 
23 Heptane 0 0 0 3.173 0 
24 Hexane 0 0 0 2.668 0 
25 Isooctane 0 0 0 3.106 0 
26 Isopropyl acetate 0.055 0.57 0 2.546 0.47 
27 Isopropyl ether 0 0.19 0 2.482 0.45 
28 Methanol 0.278 0.44 0.43 0.97 0.47 
29 Methyl acetate 0.142 0.64 0 1.911 0.45 
30 Methyl ethyl ketone 0.166 0.7 0 2.287 0.51 
31 Methyl isobutyl ketone 0.111 0.65 0 3.089 0.51 
32 Methyl isopropyl ketone 0.134 0.65 0 2.692 0.51 
33 Methyl tetrahydrofuran 0.241 0.48 0 2.82 0.53 
34 Methylcyclohexane 0.244 0.1 0 3.323 0 
35 Nitromethane 0.313 0.95 0.06 1.892 0.31 
36 Pentane 0 0 0 2.162 0 
37 Propyl acetate 0.092 0.6 0 2.819 0.45 
38 Tetrahydrofuran 0.289 0.52 0 2.636 0.48 
39 Toluene 0.601 0.52 0 3.325 0.14 
Table 6. Solute descriptors of organic solvents 
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The prediction of the retention times of residual solvents under temperature-programmed 
conditions involves three steps:  
i. The retention times of four different temperatures within the range of the temperature-
programmed conditions, such as 40°C, 60°C, 80°C and 100°C is predicted using the 
solvation parameter model. 
ii. The values of A and B is calculated using Eq.(3) and the retention times obtained from 
step (i).  
iii. The retention time of residual solvent under temperature-programmed conditions is 
calculated according to Cavelli’s theory.  
 
System constant ( b=0 in all cases) Statistics  
Column 
T (°C) 
r s a l c ┩ SE F 
SPB-1 40 -0.162 0.297 0.355 0.766 -1.916 0.992 0.050 511 
 60 -0.108 0.254 0.270 0.692 -1.730 0.993 0.043 582 
 80 -0.065 0.223 0.210 0.628 -1.570 0.994 0.036 685 
 100 -0.024 0.190 0.162 0.569 -1.425 0.994 0.032 759 
HP-5 40 -0.155 0.435 0.385 0.769 -2.021 0.993 0.045 602 
 60 -0.094 0.373 0.301 0.696 -1.825 0.994 0.039 695 
 80 -0.045 0.324 0.235 0.629 -1.649 0.995 0.033 785 
 100 -0.009 0.276 0.185 0.572 -1.493 0.995 0.029 858 
HP-35 40 -0.057 0.926 0.544 0.760 -2.359 0.993 0.045 600 
 60 0.009 0.809 0.487 0.690 -2.134 0.994 0.038 678 
 80 0.067 0.710 0.376 0.618 -1.912 0.995 0.032 810 
 100 0.108 0.627 0.313 0.560 -1.713 0.995 0.029 849 
DB-624 40 -0.245 0.689 0.815 0.765 -2.193 0.993 0.041 637 
 60 -0.173 0.601 0.653 0.687 -1.967 0.994 0.035 710 
 80 -0.114 0.529 0.531 0.621 -1.777 0.995 0.031 773 
 100 -0.068 0.471 0.433 0.563 -1.611 0.994 0.029 758 
AT-225 40 -0.178 1.680 1.878 0.707 -2.803 0.994 0.047 682 
 60 -0.098 1.530 1.627 0.630 -2.533 0.994 0.044 657 
 80 -0.040 1.397 1.415 0.564 -2.299 0.993 0.041 615 
 100 0.009 1.293 1.254 0.512 -2.115 0.992 0.041 534 
ZB-WAX 40 0.401 2.007 3.045 0.575 -2.712 0.991 0.080 448 
 60 0.388 1.801 2.698 0.517 -2.448 0.992 0.068 504 
 80 0.384 1.617 2.378 0.463 -2.205 0.992 0.058 542 
 100 0.373 1.467 2.126 0.421 -2.011 0.992 0.052 558 
┩= Overall multiple linear regression correlation coefficient; SE= standard error in the estimate;  
F = Fischer statistic; n = 39 in all cases. 
Table 7. System constants for six columns at different temperatures 
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4.3.3 Prediction of system constants at different temperatures 
The system constants (Eq. (2)) were summarized in Table 7. The overall multiple linear 
regression coefficients (┩) of the solvation parameter models were all above 0.990 which 
indicated that the solvation parameter models could predict the retention times of the 
organic solvents.  
The relationship between system constant and temperature was also studied. The system 
constants were reversely correlated with temperatures as indicated in the following 
equation: 
 my n
T
= +  (4) 
where y is a system constant, T is the column temperature, and m and n are coefficient 
obtained by linear regression (Table 8).  
 
Column System constant m n r2 
r -267.12 0.6928 0.9996 
s 205.75 -0.3614 0.9985 
a 374.78 -0.8481 0.9938 
l 382.6 -0.4565 1.0000 
SPB-1 
c -954.11 1.1333 1.0000 
r -323.08 0.852 0.9981 
s 320.86 -0.5702 0.9995 
a 455.2 -1.0223 0.9935 
l 389.59 -0.4709 0.9999 
HP-5 
c -1044.4 1.2913 0.9998 
r -323.84 0.9799 0.9973 
s 582.54 -0.9376 0.9994 
a 452.13 -0.9015 0.9994 
l 392.27 -0.4915 0.9992 
HP-35 
c -1260.1 1.6599 0.9992 
r -345.47 0.8615 0.9979 
s 424.98 -0.6718 0.9984 
a 743.05 -1.5676 0.9963 
l 392.84 -0.4912 0.9998 
DB-624 
c -1131.9 1.4272 0.9997 
r -362.72 0.9853 0.9961 
s 756.94 -0.7413 0.9991 
a 1220.1 -2.029 0.9980 
l 380.94 -0.5121 0.9988 
AT-225 
c -1344.5 1.4992 0.9990 
r 53.664 0.2285 0.9892 
s 1054.7 -1.3651 0.9996 
a 1798.9 -2.7054 0.9995 
l 301.68 -0.3893 0.9994 
ZB-WAX 
c -1371.4 1.6713 0.9996 
Table 8. Fitted regression coefficients for Eq. (4) 
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These coefficients were used to further predict the retention at any temperature in the 
studied range.  
For instance, the system constants of SPB-1 column were predicted at 50°C using Eq. (4) as 
follows: r = -0.134, s = 0.276, a = 0.312, l = 0.728, and c = -1.821. Meanwhile the system 
constants of this column were determined under 50°C and r = -0.145, s = 0.282, a = 0.326, l = 
0.734, and c = -1.837. The results showed that the differences between predicted and 
experimental values were very small, and the system constants can be well predicted at any 
temperature within the ranges of 40°C to 100°C. 
4.3.4 Application in the process of method development  
The control of 8 residual solvents (methanol, ethanol, dichloromethane, chloroform, hexane, 
benzene, methyl isobutyl ketone and toluene) was evaluated in rabeprazole sodium 
formulations. Methyl ethyl ketone was used as internal standard (IS). The solvation 
parameter models were used to select columns under isothermal conditions and to optimize 
chromatographic conditions under temperature-programmed conditions in the analysis of 
residual solvents in rabeprazole sodium. 
4.3.4.1 Column selection under isothermal conditions 
The retention times of these solvents were predicted on SPB-1 (non polar), ZB-WAX (polar) 
and DB-624 (moderately polar) columns at 40°C using the solvation parameter model. The 
optimum column was selected according to the results shown in Table 9. Hexane and 
chloroform could not be separated on the SPB-1 column. On the HP-INNOWAX column, the 
predicted retention time of methanol was close to that of methyl ethyl ketone, as were 
ethanol and benzene. On the DB-624 column, all the residual solvents could be separated 
according to the predicted retention times, therefore the DB-624 column was selected in this 
experiment. The residual solvents were determined on the DB-624 column, and the results 
were compared with the predicted results shown in Table 10. These findings indicated that 
the predicted results were consistent with the experimental results, and that the 8 residual 
solvents could be separated on this column.  
 
Predicted t R (min) 
Organic solvent 
SPB-1 ZB-WAX DB-624 
Methanol 1.838 5.098 2.551 
Ethanol 2.157 5.320 3.606 
Dichloromethane 2.800 4.398 5.179 
Methyl ethyl ketone (IS) 3.704 5.142 8.172 
Chloroform 4.228 6.832 9.167 
Hexane 4.315 1.766 6.271 
Benzene 5.398 5.336 10.836 
Methyl isobutyl ketone 10.130 8.016 25.493 
Toluene 11.457 9.161 27.114 
Table 9. Predicted retention times of residual solvents in rabeprazole sodium on 3 different 
columns at 40°C using Eqs. (1) and (2) 
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tR (min)  
Organic solvent Predicted Experimental ΔtR 
Methanol 2.551 2.606 0.055 
Ethanol 3.606 3.539 -0.067 
Dichloromethane 5.179 4.928 -0.251 
Hexane 6.271 6.296 0.025 
Methyl ethyl ketone (IS) 8.172 8.199 0.027 
Chloroform 9.167 9.190 0.023 
Benzene 10.836 10.833 -0.003 
Methyl isobutyl ketone 25.493 25.016 -0.477 
Toluene 27.114 27.409 0.295 
Table 10. Comparison between the predicted and experimental retention time of residual 
solvents in rabeprazole sodium on DB-624 column at 40°C using Eqs. (1) and (2) 
 
 
1-Methanol; 2-Ethanol; 3-Dichloromethane; 4-Hexane; 5-Methyl ethyl ketone (IS); 6-Chloroform;  
7-Benzene; 8-Methyl isobutyl ketone; 9-Toluene; 
Note: Predicted retention times of each organic compound were indicated by the vertical bars inserted 
in the chromatogram 
Fig. 5. Chromatogram of 8 organic solvents under temperature-programmed conditions on 
DB-624 column 
4.3.4.2 Optimization of chromatographic conditions under temperature-programmed 
conditions 
From Table 10, it can be seen that the separation of these 8 residual solvents on the DB-624 
column at 40°C took approximately 30 min, and no peak was eluted between 10 and 25 min, 
therefore temperature-programmed conditions can be used to shorten the analysis time. The 
method for predicting retention time under temperature-programmed conditions can be 
used to optimize the chromatographic conditions. The retention times of the solvents under 
designated temperature-programmed conditions were first calculated, and according to the 
predicted retention times, separations among the solvents were evaluated. If some of the 
solvents could not be separated under that condition, the temperature program was revised 
and the retention times were recalculated. This process was repeated until optimal 
chromatographic conditions were found under which all the solvents could be separated. In 
this case, the temperature-programmed conditions were as follows: oven temperature was 
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maintained at 40°C for 10 min, and then raised to 120°C by a rate of 20°C/min for 2 min. 
These 8 residual solvents were determined under the optimized conditions, and the results 
were compared with the predicted results (Fig. 5). These findings indicated that the 
predicted results were consistent with the experimental results, and that the 8 residual 
solvents were separated within 15 min. The analysis time was decreased by 15 min 
compared to the analysis time under isothermal conditions. Therefore workload and time 
were dramatically decreased following the process of method optimization using the 
proposed approach.  
5. Conclusion 
Residual solvents from the processes in the manufacture of pharmaceuticals are a problem 
and must be removed. The ICH guideline is already accepted by different pharmacopeias. 
GC analysis is the ideal methodology for residual solvent analysis. Now the official method 
for sample preparation is still static headspace analysis, which gives a high level of 
automation from the instrumentation currently available and has a low impact on GC 
column life. Other methods such as SPME, MHS-SDME are useful alternative methods for 
residual solvents testing.  
From the regulatory perspective, each pharmacopoeia focused on comprehensive analysis of 
residual solvents in pharmaceuticals. The official methods in USP and EP use two system 
and all the organic solvent reference standards to screening residual solvents. The 
established database for residual solvents analysis was adopted by ChP. Different from USP 
and EP, reference standards were not required for all organic solvents. Organic solvents 
having the same or similar retention times on one column usually have quite different 
retention times on the column with opposite polarity. The nature of the organic solvents can 
be identified using the two columns. The screening database was used to make a full-scale 
screening of the residual solvents in the pharmaceuticals. Only a few organic solvent 
reference standards were needed to confirm the screening result. If there are residual 
solvents that were not mentioned in the specification or production process, first class 
solvents or unknown solvents were found, that can be analyzed by GC-MS and GC-FTIR, 
using the confirmation database to make a confirmation. The dababase system can solve the 
difficult problem of unknown residual solvents determination, making it a powerful tool for 
determining residual solvents in pharmaceuticals. 
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